Early oral intake and early removal of nasogastric tube post-esophagectomy: A systematic review and meta-analysis.

anastomotic leak aspiration pneumonia early oral intake esophagectomy nasogastric tube perioperative complications

Journal

Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728

Informations de publication

Date de publication:
05 2022
Historique:
revised: 26 07 2021
received: 14 06 2021
accepted: 06 08 2021
pubmed: 9 9 2021
medline: 25 5 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

Early oral intake (EOI: initiated within 1 day) and early nasogastric tube removal (ENR: removed ≤2 days) post-esophagectomy is controversial and subject to significant variation. Our aim is to provide the most up-to-date evidence from published randomized controlled trials (RCTs) addressing both topics. We searched MEDLINE and Embase (1946-06/2019) for RCTs that investigated the effect of EOI and/or ENR post-esophagectomy with gastric conduit for reconstruction. Our main outcomes of interest were anastomotic leak, aspiration pneumonia, mortality, and length of hospital stay (LOS). Pooled mean differences (MD) and risk ratios (RR) estimates were obtained using a DerSimonian random effects model. Two reviewers screened 613 abstracts and identified 6 RCTs eligible for inclusion; 2 regarding EOI and 4 for ENR. For EOI (2 studies, n = 389), was not associated with differences in risk of: anastomotic leak (RR: 1.01; 95% CI: 0.407, 2.500; I Our analysis showed that EOI as well as ENR post-esophagectomy do not significantly increase the risk of anastomotic leak, pneumonia, and mortality. The LOS was significantly shorter in the EOI group, and there was no significant difference in the ENR group. A paucity of RCTs has evaluated this question, highlighting the need for further high-quality evidence to address these vital aspects to post-esophagectomy care. CRD42019138600.

Sections du résumé

BACKGROUND
Early oral intake (EOI: initiated within 1 day) and early nasogastric tube removal (ENR: removed ≤2 days) post-esophagectomy is controversial and subject to significant variation.
AIM
Our aim is to provide the most up-to-date evidence from published randomized controlled trials (RCTs) addressing both topics.
METHODS
We searched MEDLINE and Embase (1946-06/2019) for RCTs that investigated the effect of EOI and/or ENR post-esophagectomy with gastric conduit for reconstruction. Our main outcomes of interest were anastomotic leak, aspiration pneumonia, mortality, and length of hospital stay (LOS). Pooled mean differences (MD) and risk ratios (RR) estimates were obtained using a DerSimonian random effects model.
RESULTS
Two reviewers screened 613 abstracts and identified 6 RCTs eligible for inclusion; 2 regarding EOI and 4 for ENR. For EOI (2 studies, n = 389), was not associated with differences in risk of: anastomotic leak (RR: 1.01; 95% CI: 0.407, 2.500; I
CONCLUSIONS
Our analysis showed that EOI as well as ENR post-esophagectomy do not significantly increase the risk of anastomotic leak, pneumonia, and mortality. The LOS was significantly shorter in the EOI group, and there was no significant difference in the ENR group. A paucity of RCTs has evaluated this question, highlighting the need for further high-quality evidence to address these vital aspects to post-esophagectomy care.
SYSTEMATIC REVIEW REGISTRATION
CRD42019138600.

Identifiants

pubmed: 34494402
doi: 10.1002/cnr2.1538
pmc: PMC9124520
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1538

Informations de copyright

© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Références

World J Surg. 2017 Jun;41(6):1575-1583
pubmed: 28078353
Support Care Cancer. 2013 Mar;21(3):707-14
pubmed: 22933129
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Oman Med J. 2016 May;31(3):182-7
pubmed: 27162588
World J Surg. 2013 Oct;37(10):2372-8
pubmed: 23807122
J Gastrointest Surg. 2014 Feb;18(2):304-9
pubmed: 24002761
Cancer Rep (Hoboken). 2022 May;5(5):e1538
pubmed: 34494402
Eur J Cardiothorac Surg. 2015 Feb;47(2):227-33
pubmed: 24743002
BMJ Open. 2014 Jun 06;4(6):e004557
pubmed: 24907243
BMJ Open. 2016 Aug 05;6(8):e011979
pubmed: 27496239
Int J Technol Assess Health Care. 2000 Autumn;16(4):1109-19
pubmed: 11155831
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
BJOG. 2018 Dec;125(13):1716
pubmed: 29916205
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):441-7
pubmed: 24916581
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007635
pubmed: 21328298

Auteurs

Suha Kaaki (S)

Department of Surgery, Division of Thoracic Surgery, The Ottawa Hospital, Ottawa, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Emma J M Grigor (EJM)

Department of Surgery, Division of Thoracic Surgery, The Ottawa Hospital, Ottawa, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.

Donna E Maziak (DE)

Department of Surgery, Division of Thoracic Surgery, The Ottawa Hospital, Ottawa, Canada.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.

Andrew J E Seely (AJE)

Department of Surgery, Division of Thoracic Surgery, The Ottawa Hospital, Ottawa, Canada.
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH